Correlation Between Equillium and CureVac NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Equillium and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and CureVac NV, you can compare the effects of market volatilities on Equillium and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and CureVac NV.

Diversification Opportunities for Equillium and CureVac NV

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between Equillium and CureVac is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Equillium i.e., Equillium and CureVac NV go up and down completely randomly.

Pair Corralation between Equillium and CureVac NV

Allowing for the 90-day total investment horizon Equillium is expected to under-perform the CureVac NV. In addition to that, Equillium is 2.42 times more volatile than CureVac NV. It trades about 0.0 of its total potential returns per unit of risk. CureVac NV is currently generating about 0.03 per unit of volatility. If you would invest  309.00  in CureVac NV on September 12, 2024 and sell it today you would earn a total of  12.00  from holding CureVac NV or generate 3.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Equillium  vs.  CureVac NV

 Performance 
       Timeline  
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
CureVac NV 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in CureVac NV are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, CureVac NV may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Equillium and CureVac NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Equillium and CureVac NV

The main advantage of trading using opposite Equillium and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.
The idea behind Equillium and CureVac NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings